Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 31 Records) |
Query Trace: Infection and F3[original query] |
---|
Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. Journal of gastroenterology and hepatology 2003 Oct 18 (10): 1139-43. Suzuki Seiji, Tanaka Yasuhito, Orito Etsuro, Sugauchi Fuminaka, Hasegawa Izumi, Sakurai Mayumi, Fujiwara Kei, Ohno Tomoyoshi, Ueda Ryuzo, Mizokami Masas |
Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C. Journal of viral hepatitis 2006 Nov 13 (11): 770-4. Dai C-Y, Chuang W-L, Lee L-P, Chen S-C, Hou N-J, Lin Z-Y, Hsieh M-Y, Hsieh M-Y, Wang L-Y, Chang W-Y, Yu M |
Effect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infection. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2006 1 39 (1): 79-83. Souza R M, Freitas L A R, Lyra A C, Moraes C F, Braga E L, Lyra L G |
CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population. World journal of gastroenterology : WJG 2007 Apr 13 (15): 2187-92. Montes-Cano M-A, Garcia-Lozano J-R, Aguilar-Reina J, Romero-Gomez M, Barroso N, Nunez-Roldan A, Gonzalez-Escribano M |
PTPN22 C1858T polymorphism and the outcome of hepatitis C virus infection. Viral immunology 2008 Dec 21 (4): 491-4. Montes-Cano M A, García-Lozano J R, Aguilar-Reina J, Romero-Gómez M, Barroso N, Nuñez-Roldán A, Martín J, González-Escribano M |
Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias? Hepatology (Baltimore, Md.) 2012 Jan 55 (1): 30-8. Beinhardt Sandra, Staettermayer Albert F, Rutter Karoline, Maresch Judith, Scherzer Thomas M, Steindl-Munda Petra, Hofer Harald, Ferenci Pet |
KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C. Human immunology 2011 Nov 72 (11): 1074-8. Marangon Amanda Vansan, Silva Giovanni Faria, de Moraes Camila Fernanda Verdichio, Grotto Rejane Maria Tomasini, Pardini Maria Inês de Moura Campos, de Pauli Dayse Sousa, Sell Ana Maria, Visentainer Jeane Eliete Laguila, Moliterno Ricardo Alber |
HLA class II alleles and chronic hepatitis C virus infection. Scandinavian journal of immunology 2011 Sep 74 (3): 282-7. Cangussu L O F, Teixeira R, Campos E F, Rampim G F, Mingoti S A, Martins-Filho O A, Gerbase-DeLima |
A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Mar 18 (3): 298-304. do O Nicole T, Eurich Dennis, Schmitz Petra, Schmeding Maximilian, Heidenhain Christoph, Bahra Marcus, Trautwein Christian, Neuhaus Peter, Neumann Ulf P, Wasmuth Hermann |
Human platelet antigen genotype is associated with progression of fibrosis in chronic hepatitis C. Journal of medical virology 2012 Jan 84 (1): 56-60. Silva Giovanni Faria, Grotto Rejane Maria Tommasini, Verdichio-Moraes Camila Fernanda, Corvino Silvia Maria, Ferrasi Adriana Camargo, Silveira Liciana Vaz de Arruda, Pardini Maria Inês de Moura Camp |
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients. AIDS (London, England) 2013 Nov 27 (17): 2707-14. Mandorfer Mattias, Neukam Karin, Reiberger Thomas, Payer Berit A, Rivero Antonio, Puoti Massimo, Boesecke Christoph, Baumgarten Axel, Grzeszczuk Anna, Zangerle Robert, Meyer-Olson Dirk, Rockstroh Jürgen K, Trauner Michael, Pineda Juan A, Peck-Radosavljevic Mark |
Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers. Journal of acquired immune deficiency syndromes (1999) 2013 Dec 64 (5): 434-42. Fernández-Rodríguez Amanda, Berenguer Juan, Jiménez-Sousa María A, Guzmán-Fulgencio María, Micheloud Dariela, Miralles Pilar, López Juan Carlos, Bellón José María, Aldamiz-Echevarria Teresa, García-Broncano Pilar, Carrero Ana, Alvarez Emilio, Resino Salvad |
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C. Journal of virology 2014 Jun 88 (11): 6394-402. Estrabaud Emilie, Lapalus Martine, Broët Philippe, Appourchaux Kevin, De Muynck Simon, Lada Olivier, Martinot-Peignoux Michelle, Bièche Ivan, Valla Dominique, Bedossa Pierre, Marcellin Patrick, Vidaud Michel, Asselah Tar |
Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males. International journal of molecular epidemiology and genetics 2014 5 (3): 164-76. White Donna L, Liu Yanhong, Garcia Jose, El-Serag Hashem B, Jiao Li, Tsavachidis Spiridon, Franco Luis M, Lee Ju-Seog, Tavakoli-Tabasi Shahriar, Moore David, Goldman Radoslav, Kuzniarek Jill, Ramsey David J, Kanwal Fasiha, Marcelli Mar |
WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients. PloS one 2013 8 (12): e84407. Liu Yanhong, El-Serag Hashem B, Jiao Li, Lee Juseog, Moore David, Franco Luis M, Tavakoli-Tabasi Shahriar, Tsavachidis Spiridon, Kuzniarek Jill, Ramsey David J, White Donna |
Glutathione S-Transferase M1 and T1 Gene Polymorphisms and the Outcome of Chronic Hepatitis C Virus Infection in Egyptian Patients. Annals of human genetics 2015 Nov . Ibrahim Amany M, Ahmed Hanan S, Alazizi Nashwa M, Mansour Marwa A, Mansour Shymaa |
Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection. Journal of gastroenterology and hepatology 2014 29 (7): 1458-62. Kitson Matthew T, George Jacob, Dore Gregory J, Leung Reynold, Button Peter, McCaughan Geoffrey W, Grawford Darrell H G, Siebert William, Weltman Martin D, Cheng Wendy S C, Roberts Stuart |
Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease. Investigacio?n cli?nica 2016 Mar 57 (1): 38-46. Puche Mary L, Kay-Valero Sharon, Michelli Pedro, Oropeza Maria D, Loureiro Carmen L, Devesa Marisol, Dagher Lucy, Puol Flor |
Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C. Meta gene 2016 Sep 9 90-6. Moreira Sara Tatiana, Silva Giovanni Faria, de Moraes Camila Fernanda Verdichio, Grotto Rejane Maria Tomasini, de Moura Campos Pardini Maria Inês, Bicalho Maria da Graça, Moliterno Ricardo Alber |
Real-world effectiveness of peginterferon a-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2016 Feb . Marotta P, Bailey R, Elkashab M, Farley J, Feinman S V, Peltekian K, Poliquin M, Witt-Sullivan H, Rampakakis E, Drolet M, Cooper |
IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Liver international : official journal of the International Association for the Study of the Liver 2016 Feb . Jiménez-Sousa María A, Berenguer Juan, Rallón Norma, Pineda-Tenor Daniel, Echevarria Teresa Aldamiz-, Soriano Vicente, García-Álvarez Mónica, Vazquez-Morón Sonia, Restrepo Clara, Carrero Ana, Benito José Miguel, Resino Salvad |
SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4. Archives of virology 2017 Jul . Youssef Samar S, Hamdy Nadia |
Interferon lambda 4 rs368234815 TT>?G variant is associated with liver damage in patients with nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 2017 Jul . Petta Salvatore, Valenti Luca, Tuttolomondo Antonino, Dongiovanni Paola, Pipitone Rosaria Maria, Cammà Calogero, Cabibi Daniela, Di Marco Vito, Fracanzani Anna Ludovica, Badiali Sara, Nobili Valerio, Fargion Silvia, Grimaudo Stefania, Craxì Anton |
Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. Alimentary pharmacology & therapeutics 2017 1 45 (5): 681-687. Elsharkawy A, Fouad R, El Akel W, El Raziky M, Hassany M, Shiha G, Said M, Motawea I, El Demerdash T, Seif S, Gaballah A, El Shazly Y, Makhlouf M A M, Waked I, Abdelaziz A O, Yosry A, El Serafy M, Thursz M, Doss W, Esmat |
Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis C. Journal of medical virology 2019 Feb . Ghasemi Ali, Zadsar Maryam, Shaiegan Mojgan, Samiei Shahram, Namvar Ali, Rasouli Mahboobeh, Moosanejad Molo |
Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C. Journal of gastrointestinal and liver diseases : JGLD 2019 Dec 28 (4): 449-456. Simili Angelo, Mazzella Giuseppe, Ravaioli Federico, Festi Davide, Bacchi-Reggiani Maria Letizia, Porro Alberto, Bazzoli Franco, Azzaroli Frances |
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study. Liver international : official journal of the International Association for the Study of the Liver 2019 11 40 (5): 1042-1051. Asselah Tarik, Pol Stanislas, Hezode Christophe, Loustaud-Ratti Veronique, Leroy Vincent, Ahmed Si Nafa Si, Ozenne Violaine, Bronowicki Jean-Pierre, Larrey Dominique, Tran Albert, Alric Laurent, Nguyen-Khac Eric, Robertson Michael N, Hanna George J, Brown Deborah, Asante-Appiah Ernest, Su Feng-Hsiu, Hwang Peggy, Hall Jessie Durrand, Guidoum Amir, Hagen Karin, Haber Barbara A, Talwani Rohit, Serfaty Lawren |
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil. Annals of hepatology 2020 Sep . Peribañez-Gonzalez Mario, Cheinquer Hugo, Rodrigues Lino, Lima Maria Patelli, Álvares-da-Silva Mário Reis, Madruga José, Parise Edison Roberto, Pessoa Mário Guimarães, Furtado Juvencio, Villanova Marcia, Ferreira Adalgisa, Mazzoleni Felipe, Nascimento Ecio, Silva Giovanni Faria, Fredrick Linda, Krishnan Preethi, Burroughs Margaret, Reuter Tan |
Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients. European journal of hospital pharmacy : science and practice 2020 4 27 (e1): e41-e47. Margusino-Framiñán Luis, Cid-Silva Purificación, Rotea-Salvo Sandra, Mena-de-Cea Álvaro, Suárez-López Francisco, Vázquez-Rodríguez Pilar, Delgado-Blanco Manuel, Sanclaudio-Luhia Ana Isabel, Martín-Herranz Isabel, Castro-Iglesias Ángel |
Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study. Gene 2022 Feb 820 146235. Kang Qian, Xu Jinghang, Luo Hao, Tan Ning, Chen Hongyu, Cheng Ran, Pan Jiali, Han Yifan, Yang Yuqing, Liu Dan, Xi Hongli, Yu Min, Xu Xiaoyu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: